Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMixing semaglutide powder with its reconstitution solution requires precise technique to produce a stable, correctly concentrated dose. If you have been prescribed a compounded or research-grade preparation that needs reconstituting, each step matters: the wrong volume, the wrong mixing method or poor aseptic technique can affect both safety and how well the medicine works. This guide covers the general process — but a critical point first: licensed semaglutide in the UK comes ready to inject and does not need reconstituting. Wegovy (the weight-management brand) and Ozempic (the diabetes brand) are pre-filled pens supplied by Novo Nordisk that require no mixing whatsoever. If you have been told you need to mix semaglutide yourself, it is worth understanding exactly what you have been given and whether it is sourced through the licensed UK supply chain — a question our prescribers hear most weeks.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Before touching any vial, the first step is confirming that what you hold is what it claims to be. Powdered semaglutide packaged as a vial for reconstitution is not a licensed UK presentation. The MHRA grants marketing authorisation to specific finished products, in semaglutide's case, those are the Wegovy and Ozempic pre-filled injection pens. Powdered preparations sold online, sometimes described as "research peptides", fall outside that authorisation. The MHRA has warned publicly about fake and unlicensed weight-loss injectables circulating through social media and unregistered websites; in some cases tested products have contained entirely different substances. You can read the NHS's overview of semaglutide medicines to see what licensed preparations look like. If the product in your hand does not match the pre-filled pen format described there, that is a significant red flag. Verify any online pharmacy supplying injectable medicines on the GPhC pharmacy register before purchasing anything.
For contexts where reconstitution of an injectable peptide is genuinely appropriate) for example, in a licensed clinical or compounding setting, the general process follows established aseptic principles. The bacteriostatic water or other specified diluent (typically sterile water for injection or bacteriostatic sodium chloride, as specified by the protocol) is drawn into a syringe using a fresh needle. The needle is inserted into the powder vial through the rubber stopper, and the diluent is added slowly down the side of the vial, never directly onto the powder, to minimise protein degradation and foaming. The vial is then swirled gently (never shaken vigorously) until the powder dissolves fully into a clear, colourless solution with no visible particles. Once dissolved, the resulting concentration depends on the exact volumes used; a reconstitution calculator can help confirm the arithmetic, but it does not replace the protocol provided by the prescribing clinician. The solution is drawn into the injection syringe through a fresh needle immediately before use. Detailed technique for specific preparations is covered on the how to reconstitute semaglutide page.
Reconstituted peptide solutions have limited stability windows that vary by preparation, concentration and storage conditions. Generally, bacterial contamination risk rises quickly once a vial is opened; most protocols specify refrigeration at 2–8°C and a discard window of days to weeks. Any reconstituted solution that appears cloudy, discoloured or contains particles should be discarded and not injected. For comparison, the licensed semaglutide solution in pre-filled Wegovy pens is manufactured under pharmaceutical-grade conditions with defined shelf life, quality-control release testing and cold-chain distribution, stability standards that are not replicable at home. The reconstitution guide goes further on the specifics of storage after mixing. Always follow the precise instructions provided with any compounded or clinical preparation; if instructions were not provided, that is itself a warning sign. The MHRA's Yellow Card reporting service accepts reports of substandard or suspect injectable medicines.
The reconstitution question matters primarily because people researching it have often encountered unlicensed preparations online, sometimes at prices that seem attractive. It is worth being direct: a small financial saving on a powdered vial is not a saving if the product is mislabelled, contaminated or contains an entirely different compound. The licensed route (a pre-filled Wegovy pen, supplied through a GPhC-registered pharmacy following a proper prescriber review) removes every step described above. There is no powder, no diluent, no syringe, no measurement. You remove the pen cap, select the injection site and press the button. If you are trying to understand whether semaglutide for weight management is something you would be eligible for through the licensed route, the weight-loss treatments overview sets out how the process works. For those already familiar with how Wegovy is obtained legitimately in the UK, the where to buy Wegovy page explains what a compliant supply chain looks like. At nume, every treatment starts with a free consultation reviewed the same day by a GPhC-registered prescriber, no mixing, no guesswork, no DIY dosing.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.